← All Sponsors
SPONSOR

dr. Tom van der Hulle

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Renal Cell Carcinoma (RCC)
NCT07077161 Phase 2
Recruiting

Cabozantinib Dose Skipping as an Alternative to Dose Reductions

Renal Cell Carcinoma (RCC)
Netherlands View Trial →